Sullivan released a research report on the current development status and future trends of the CDMO industry
Release time：
2022-11-22
Source：
The report estimates the global and Chinese CDMO market size. From a global perspective, the CDMO industry is in a continuous trend of large-scale development, maintaining a high market prosperity. From 2017 to 2022, the global CDMO market size increased from$39. 4 billion to$63. 2 billion, with a compound annual growth rate of 12. 5%. It is expected to reach$124. 3 billion in 2025 and$231 billion in 2030.
CDMO plays an important role in the pharmaceutical innovation industry chain. With the rapid development of innovative Drug development in China, the development momentum of the CDMO industry is strong. In recent years, it has ushered in rapid growth. From 2017 to 2021, China's CDMO market size will grow from 13. 2 billion yuan to 47. 3 billion yuan, with a compound annual growth rate of 37. 7%. It is expected to reach 157. 1 billion yuan in 2025 and 355. 9 billion yuan in 2030. The CDMO industry in China has shown rapid growth above the global level, and the proportion of China's CDMO market to the global market has been increasing year by year. In 2017, the Chinese CDMO market accounted for only 5. 0%of the total global CDMO market size, and by 2021 it had expanded to 13. 2%. It is expected to occupy one fifth of the global market after 2025.
News source:On September 28, Mr. Li Dongyi, medical consulting director of Frost&Sullivan ( "Sullivan"for short ) officially released the Research Report on the Development Status and Future Trends of CDMO Industry at the 16th Sullivan Global GIL Summit·Biotechnology Investment Sub forum
Market size,CDMO
previous page
next page
previous page
next page
|
Related information